Clinical Trial Update: Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography [Phase 4]

View source ↗

Summary

Phase 4 pilot study evaluating F-18 florbetapir PET imaging for cardiac amyloidosis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Drugs mentioned

• Amyvid (florbetapir F-18) (florbetapir)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Cardiac Amyloidosis | Phase 4 | Status: COMPLETED | Results posted: 2022-04-13